Title:
MORPHOLINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/161462
Kind Code:
A1
Abstract:
A substituted morpholine derivative with a structure as shown in a formula (I). In addition, further disclosed are a pharmaceutically acceptable salt, a stereoisomer, a pharmaceutical composition and the use of the derivative.
Inventors:
HU BIN (CN)
GUAN HUIPING (CN)
YANG WEN (CN)
ZHU JINGFENG (CN)
SHI XIAOYONG (CN)
ZHANG KAI (CN)
LU RONGCHANG (CN)
GUAN HUIPING (CN)
YANG WEN (CN)
ZHU JINGFENG (CN)
SHI XIAOYONG (CN)
ZHANG KAI (CN)
LU RONGCHANG (CN)
Application Number:
PCT/CN2022/074593
Publication Date:
August 04, 2022
Filing Date:
January 28, 2022
Export Citation:
Assignee:
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD (CN)
YANGTZE RIVER PHARM GROUP CO (CN)
YANGTZE RIVER PHARM GROUP CO (CN)
International Classes:
C07D471/04; A61K31/5375; A61K31/5377; A61P11/06; A61P13/00; A61P25/04; C07D265/30; C07D413/06; C07D487/04
Domestic Patent References:
| WO2021161105A1 | 2021-08-19 | |||
| WO2021161109A1 | 2021-08-19 | |||
| WO2020174283A1 | 2020-09-03 | |||
| WO2020099923A1 | 2020-05-22 |
Foreign References:
| CN112409331A | 2021-02-26 | |||
| CN113549068A | 2021-10-26 | |||
| CN113754654A | 2021-12-07 | |||
| CN111377917A | 2020-07-07 | |||
| US20200230148A1 | 2020-07-23 |
Attorney, Agent or Firm:
ADVANCE CHINA IP LAW OFFICE (CN)
Download PDF: